Farewell to chemotherapy?
Chemotherapy. That’s the word Jana Hermann doesn’t want to hear under any circumstances. She has breast cancer; she received the diagnosis four weeks ago. She underwent surgery to remove one of her breasts and five [more]
March 2017
A breakthrough business model for drug development
Anna Wagstaff looks at changes in the business, regulatory and science arenas that could open the way to delivering better cancer treatments, faster and cheaper. Of 91 new therapies approved for solid tumours between 2002 [more]